Fangming Wang

10PUBLICATIONS

12CO-AUTHORS

Cancer diagnosisCancer therapy (excl. chemotherapy and radiation therapy)Medical biotechnology diagnostics (incl. biosensors)Predictive and prognostic markersMedical infection agents (incl. prions)

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (10)

Sort by Publication Date:

|Jun 26, 2026

Development and Validation of a Novel Indicator for Differential Diagnosis of Clinically Significant Prostate Cancer Based on Comprehensive Hematological Testing.

|Feb 23, 2026

Clinical Characteristics and Management of Two Cases of Complete Androgen Insensitivity Syndrome With Germ Cell Tumors.

Fangming Wang, Dong Wang, Jianxing Li

|Jan 15, 2026

Reliability of Negative Prostate MRI for Biopsy Decision-Making in the Male Han Chinese Population.

Fangming Wang, Yan Zhang, Meng Fu

|Jun 13, 2022

Combined treatment with anti-PSMA CAR NK-92 cell and anti-PD-L1 monoclonal antibody enhances the antitumour efficacy against castration-resistant prostate cancer.

Fangming Wang, Liyuan Wu, Le Yin

|Apr 22, 2022

Allogeneic Expanded Human Peripheral NK Cells Control Prostate Cancer Growth in a Preclinical Mouse Model of Castration-Resistant Prostate Cancer.

Fangming Wang, Xuejiao Dong, Jing Wang

|Feb 03, 2021

Systemic Coagulation Markers Especially Fibrinogen Are Closely Associated with the Aggressiveness of Prostate Cancer in Patients Who Underwent Transrectal Ultrasound-Guided Prostate Biopsy.

Fang-Ming Wang, Nian-Zeng Xing

Pageof 2

Frequent Collaborators

Lijiang Sun

Nianzeng Xing

Guiming Zhang

Jianxing Li

Yong Liu

Yan Zhang

Zhonghan Zhou

Xiaocheng Ma

Wen Liu

Fengju Guan

Frequent Collaborators

Lijiang Sun

Nianzeng Xing

Guiming Zhang

Jianxing Li